Mubadala Bio has launched new hemodialysis products through its subsidiary Wellpharma, one of its Abu Dhabi-based manufacturing facilities.
Emirates Drug Establishment and Mubadala Bio Limited have signed a memorandum of understanding (MoU) to strengthen and advance the UAE’s medical products manufacturing sector as well as supporting national efforts to enhance pharmaceutical security and localise vital drug industries.
Eli Lilly and Company (Lilly) and Mubadala Bio have announced a strategic collaboration to advance the localised packaging and logistics of Lilly’s GLP-1 medicines in Abu Dhabi, marking an important step in a shared commitment to advancing the emirate’s growing life sciences ecosystem.
